12 August 2009 in Neuropsychopharmacology
12 February 2014 in Neuropsychopharmacology
6 September 2011 in Journal of Neurochemistry
J. Neurochem. (2011) 119, 785–790. β‐Lactotensin (His‐Ile‐Arg‐Leu) is a bioactive peptide derived from bovine milk β‐lactoglobulin, acting as a natural agonist for neurotensin receptors. We found that β‐lactotensin exhibited anxiolytic‐like activity in an elevated plus‐maze test after its intraperitoneal (i.p.) administration in mice. β‐Lactotensin was also orally active. The anxiolytic‐like activity of β‐lactotensin after i.p. administration was blocked by levocabastine, an antagonist for the neurotensin NTS2 receptor. β‐Lactotensin had anxiolytic‐like activity in wild‐type but not Ntsr2‐knockout mice. β‐Lactotensin increased intracellular Ca2+ flux in glial cells derived from wild‐type mice but not Ntsr2 knockout mice. These results suggest that β‐lactotensin acts as an NTS2 receptor agonist having anxiolytic‐like activity. The anxiolytic‐like activity of β‐lactotensin was also blocked by SCH23390 and SKF83566, antagonists for dopamine D1 receptor, but not by raclopride, an antagonist for D2 receptor. Taken together, β‐lactotensin may exhibit anxiolytic‐like activity via NTS2 receptor followed by D1 receptor.
11 July 2007 in Journal of Neurochemistry
24 October 2018 in The Journal of Neuroscience
Synaptic AMPAR expression controls the strength of excitatory synaptic transmission and plasticity. An excess of synaptic AMPARs leads to epilepsy in response to seizure-inducible stimulation. The appropriate regulation of AMPARs plays a crucial role in the maintenance of the excitatory/inhibitory synaptic balance; however, the detailed mechanisms underlying epilepsy remain unclear. Our previous studies have revealed that a key modification of AMPAR trafficking to and from postsynaptic membranes is the reversible, posttranslationalS-palmitoylation at the C-termini of receptors. To clarify the role of palmitoylation-dependent regulation of AMPARsin vivo, we generated GluA1 palmitoylation-deficient (Cys811 to Ser substitution) knock-in mice. These mutant male mice showed elevated seizure susceptibility and seizure-induced neuronal activity without impairments in synaptic transmission, gross brain structure, or behavior at the basal level. Disruption of the palmitoylation site was accompanied by upregulated GluA1 phosphorylation at Ser831, but not at Ser845, in the hippocampus and increased GluA1 protein expression in the cortex. Furthermore, GluA1 palmitoylation suppressed excessive spine enlargement above a certain size after LTP. Our findings indicate that an abnormality in GluA1 palmitoylation can lead to hyperexcitability in the cerebrum, which negatively affects the maintenance of network stability, resulting in epileptic seizures.SIGNIFICANCE STATEMENTAMPARs predominantly mediate excitatory synaptic transmission. AMPARs are regulated in a posttranslational, palmitoylation-dependent manner in excitatory synapses of the mammalian brain. Reversible palmitoylation dynamically controls synaptic expression and intracellular trafficking of the receptors. Here, we generated GluA1 palmitoylation-deficient knock-in mice to clarify the role of AMPAR palmitoylationin vivo. We showed that an abnormality in GluA1 palmitoylation led to hyperexcitability, resulting in epileptic seizure. This is the first identification of a specific palmitoylated protein critical for the seizure-suppressing process. Our data also provide insight into how predicted receptors such as AMPARs can effectively preserve network stability in the brain. Furthermore, these findings help to define novel key targets for developing anti-epileptic drugs.